A case of Hashimoto’s encephalopathy successfully treated with cyclophosphamide pulse therapy

  • Matsuo K
  • Koga M
  • Honda M
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Hashimoto's encephalopathy has been described as an autoimmune disorder which demonstrates favorable response to corticosteroid therapy. However, steroid-resistant cases which require additional treatment are frequently reported, and there is no consensus how such cases should be treated. We present a 69 years-old man, who progressed cognitive dysfunction in the past three months. Anti-thyroid and anti-NH(2) terminal of alpha-enolase antibodies were positive. Because initial corticosteroid therapy was ineffective, cyclophosphamide (CPA) pulse therapy was added, and his cognitive function was immediately improved. He had no relapse after tapering dose of corticosteroid for three years. CPA pulse therapy should be considered for steroid-resistant Hashimoto's encephalopathy.

Cite

CITATION STYLE

APA

Matsuo, K., Koga, M., Honda, M., & Kanda, T. (2018). A case of Hashimoto’s encephalopathy successfully treated with cyclophosphamide pulse therapy. Rinsho Shinkeigaku, 58(6), 390–394. https://doi.org/10.5692/clinicalneurol.cn-001169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free